GRABODY Trademark

Trademark Overview


On Saturday, March 21, 2020, a trademark application was filed for GRABODY with the United States Patent and Trademark Office. The USPTO has given the GRABODY trademark a serial number of 88843068. The federal status of this trademark filing is REGISTERED as of Tuesday, November 9, 2021. This trademark is owned by ABL Bio, Inc.. The GRABODY trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

ophthalmic preparations; ophthalmologic preparations; biopharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; biological preparations for medical or veterinary purposes for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases; diagnostic reagents for medical or veterinary purposes; biotechnological pharmaceutical preparations for medical purposes for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases; biological preparations for medical purposes for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases; antibodies being biological preparations for medical purposes for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for use in ...

scientific research in the fields of biomedicine; scientific research for medical purposes in the area of cancerous diseases; development of pharmaceutical preparations and medicines; provision of medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of technology for biotechnology; biotechnological research; medical research in the field of medicine; scientific research in the field of medicine; laboratory research services relating to pharmaceuticals; scientific research in the field of medicinal products; research and development of vaccines and medicines; drug discovery services; scientific research for medical purposes in the field of cancerous diseases; pharmaceutical products development; pharmaceutical research and development; research on the subject of pharmaceuticals; medical and scientific research, namely, conducting testing in the nature of clinical trials of medicines for others; medical and scientific r...
grabody

General Information


Serial Number88843068
Word MarkGRABODY
Filing DateSaturday, March 21, 2020
Status700 - REGISTERED
Status DateTuesday, November 9, 2021
Registration Number6550037
Registration DateTuesday, November 9, 2021
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 24, 2021

Trademark Statements


Indication of Colors claimedThe color(s) Black and orange is/are claimed as a feature of the mark.
Description of MarkThe mark consists of the word "GRABODY" in which the "Y" is a stylized rendering of an antibody symbol in which the light chain elements of the antibody symbol are of orange color, and in which the heavy chain elements of the antibody symbol as well as the letters "G", "R", "A", "B", "O", and "D" are of black color.
Goods and Servicesophthalmic preparations; ophthalmologic preparations; biopharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; biological preparations for medical or veterinary purposes for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases; diagnostic reagents for medical or veterinary purposes; biotechnological pharmaceutical preparations for medical purposes for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases; biological preparations for medical purposes for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases; antibodies being biological preparations for medical purposes for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations acting on the central nervous system; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for the treatment of Parkinson's disease; anti-cancer preparations; tumor suppressing agents; immunostimulants; pharmaceutical compositions, namely, pharmaceutical preparations for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases
Goods and Servicesscientific research in the fields of biomedicine; scientific research for medical purposes in the area of cancerous diseases; development of pharmaceutical preparations and medicines; provision of medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of technology for biotechnology; biotechnological research; medical research in the field of medicine; scientific research in the field of medicine; laboratory research services relating to pharmaceuticals; scientific research in the field of medicinal products; research and development of vaccines and medicines; drug discovery services; scientific research for medical purposes in the field of cancerous diseases; pharmaceutical products development; pharmaceutical research and development; research on the subject of pharmaceuticals; medical and scientific research, namely, conducting testing in the nature of clinical trials of medicines for others; medical and scientific research, namely, conducting studies in the nature of clinical trials of medicines for others; development of cell therapy products; scientific research in the field of pharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 25, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 25, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameABL Bio, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGyeonggi-do 13488
KR

Party NameABL Bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGyeonggi-do 13488
KR

Party NameABL Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGyeonggi-do 13488
KR

Trademark Events


Event DateEvent Description
Tuesday, November 9, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, August 24, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 24, 2021PUBLISHED FOR OPPOSITION
Wednesday, August 4, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 20, 2021CASE RETURNED TO EXAMINATION
Tuesday, July 20, 2021NOTICE OF ALLOWANCE CANCELLED
Monday, July 12, 2021ASSIGNED TO PETITION STAFF
Friday, June 25, 2021TEAS PETITION TO AMEND BASIS RECEIVED
Thursday, June 24, 2021TEAS PETITION TO AMEND BASIS RECEIVED
Tuesday, March 9, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, January 24, 2021EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Thursday, October 15, 2020EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, September 15, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 15, 2020PUBLISHED FOR OPPOSITION
Wednesday, August 26, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 7, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 5, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 4, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 4, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 21, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 21, 2020NON-FINAL ACTION E-MAILED
Tuesday, April 21, 2020NON-FINAL ACTION WRITTEN
Tuesday, April 21, 2020ASSIGNED TO EXAMINER
Thursday, March 26, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, March 25, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, March 25, 2020NEW APPLICATION ENTERED IN TRAM